Greek drug pricing amendment expected to make over USD600 mil. in annual savings

The effect of the amendment on the Greek pharmaceutical industry will probably be very negative, since larger producers, and those from low-cost production countries, will be better able to absorb the impact of the low prices than local firms ...

READ THE ORIGINAL POST AT www.ihs.com